SOURCE: Leerink Swann & Company

June 30, 2005 10:10 ET

Leerink Swann & Company Initiates Coverage of Medco Health Solutions, Inc. (NYSE: MHS)

BOSTON, MA -- (MARKET WIRE) -- June 30, 2005 -- This morning, Senior Health Care Services Analyst, Ann Hynes, initiated coverage of Medco Health Solutions, Inc. (NYSE: MHS) with an Outperform rating. Her investment rating is based on her belief that the company will see significant earnings leverage in 2006 from generics, increased mail order penetration, potential new business and pending acquisition of Accredo Health. Medco Health is her top pick in the PBM sector.

About Medco Health Solutions, Inc.

Medco Health Solutions (NYSE: MHS) is a leader in managing prescription drug benefit programs for private and public employers, health plans, labor unions and government agencies of all sizes. Medco operates mail-order and Internet pharmacies and is headquartered in Franklin Lakes, New Jersey.

About Leerink Swann & Company

Leerink Swann & Company is an investment banking firm that provides healthcare equity research, corporate finance, and asset management services for institutional and high-net-worth clients. Leerink Swann & Company was voted the Best Firm in Biotechnology, Medical Supplies and Devices, Pharmaceuticals/Major and Pharmaceuticals/Specialty in the December 2004 Institutional Investor poll ranking the best boutique and regional firms by sector. Through its consulting affiliate, MEDACorp, Leerink Swann & Company provides biomedical-consulting services to Life Sciences companies and to the institutional investment community. MEDACorp includes thousands of biomedical professionals and practicing physicians. Leerink Swann & Company is a member NASD/SIPC.

Contact Information

  • Contact:
    John I. Fitzgerald
    Leerink Swann & Company
    (617) 918-4564